Federal Register of Legislation - Australian Government

Primary content

PB 70 of 2012 Determinations/Health as made
This determination amends the National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Determination 2012 (No. PB 58 of 2012) to add listed brands that were listed on the Pharmaceutical Benefits Scheme (PBS) after the Principal Instrument was made, but prior to the reduction day of 1 December 2012, and which have been allocated to the interim supplementary disclosure cycle, and removes brands which are no longer listed on the PBS.
Administered by: Health
Registered 21 Sep 2012
Tabling HistoryDate
Tabled HR09-Oct-2012
Tabled Senate09-Oct-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 70 of 2012

National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012

National Health Act 1953

I, STEPHEN WALDEGRAVE, Assistant Secretary (Acting), Pharmaceutical Policy Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated         20 Sep 2012

 

 

 

 

 

 

 

 

 

STEPHEN WALDEGRAVE

 

Assistant Secretary (Acting)

Pharmaceutical Policy Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

 


1              Name of Determination

       (1)     This Determination is the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012.

       (2)     This Determination may also be cited as PB 70 of 2012.

2              Commencement

                This Determination commences on the day after it is registered.

 

 

3              Amendments to PB 58 of 2012

Schedule 1 amends the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012 (PB 58 of 2012).


Schedule 1             Amendments

 

[1]      Schedule 1

 

omit:

 

1

Docetaxel

Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL with solvent

Injection

Taxotere

68.61

73.77

 

 

[2]      Schedule 1, After

 

25

Pioglitazone

Tablet 15 mg (as hydrochloride)

Oral

Pizaccord

27.74

29.83

 

             insert:

 

25A

Pioglitazone

Tablet 15 mg (as hydrochloride)

Oral

Prioten 15

27.74

29.83

 

 

[3]      Schedule 1, After

 

36

Pioglitazone

Tablet 30 mg (as hydrochloride)

Oral

Pizaccord

42.67

45.88

 

             insert:

 

36A

Pioglitazone

Tablet 30 mg (as hydrochloride)

Oral

Prioten 30

42.67

45.88

 

 

[4]      Schedule 1, After

 

47

Pioglitazone

Tablet 45 mg (as hydrochloride)

Oral

Pizaccord

55.48

59.65

 

insert:

 

47A

Pioglitazone

Tablet 45 mg (as hydrochloride)

Oral

Prioten 45

55.48

59.65

 

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.